LLY · 10-Q · 2026Q1 · Full report
Outstanding Indebtedness
ELI LILLY & Co · 2026-04-30 · Importance 61 · Surprise 32 · In source text
As of March 31, 2026, Lilly reported total debt of $43.4 billion, an increase of $0.9 billion from $42.5 billion as of December 31, 2025. The company refers readers to Note 7 for additional details on maturities and covenants. The level of indebtedness is material in absolute terms and interacts with Lilly’s capital allocation plans (including acquisitions and share repurchases). Management indicates access to committed credit facilities and commercial paper to support short-term borrowing needs.
Key facts
- Total debt was $43.4 billion as of March 31, 2026, an increase of $0.9 billion compared with $42.5 billion as of December 31, 2025. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | realized | -0.8% | Total debt was $43.4 billion as of March 31, 2026, an increase of $0.9 billion compared with $42.5 billion as of December 31, 2025. |